JAMA Network
About The Study: This study of routine screening with fecal occult blood testing found a 14% decrease in colorectal cancer mortality associated with screening. The true association of screening with reduced mortality is expected to be higher due to some coexistence of testing in the control group and colorectal cancer deaths diagnosed more than two years after screening.
Authors: Johannes Blom, M.D., Ph.D., of the Karolinska Institutet in Stockholm, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.0516)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
